Best fit
- Low-dose CT
- Stable or benign nodules
- Serial screening
Why Laudos.AI
- Nodule-level fields
- Reviewable category
- Coherent recommendation
Reporting routine
The modality defines what can fail in the final report
Lung-RADS 2 should explain why a finding is benign or probably benign while keeping recommendation and comparison traceable. Review must protect technique, relevant findings, comparison, measurements, and an impression supported by the exam itself.
Clinical use
What Lung-RADS 2 in screening reports should deliver
Lung-RADS 2 should explain why a finding is benign or probably benign while keeping recommendation and comparison traceable. Useful content is not a promise list; it is a way to test whether the report becomes easier to review and sign.
Routine example
Pick a frequent exam, dictate incomplete findings, correct the impression, and check whether the tool preserves structure, measurements, laterality, and service language.
Input
Voice, typing, templates, or loose findings should enter without forcing the radiologist to dictate formatting.
Review
The physician needs to see technique, findings, comparison, and impression before signing.
Output
The report should be ready to copy, sign, or return to the defined PACS/RIS workflow.
What turns interest into trial
- You already have volume or repeated templates.
- You need less rework before signature.
- You want a trial with your own report routine.
Buyer questions covered
Useful content for buyers already evaluating a reporting workflow.
This page is written for radiologists, coordinators, and imaging centers that need more than a generic AI explanation: they want to know whether the workflow reduces rework, preserves physician control, and deserves a real Laudos.AI trial.
Priority terms
Intent signals
- The visitor is comparing tools or moving away from Word, macros, traditional dictation, or a limited reporting product.
- The pain is specific: speed, review, templates, PACS/RIS integration, or service-level standardization.
- The right conversion is a curated workflow test, not a broad AI promise.
If these searches describe your routine, validate one frequent exam, one real template, and one physician-reviewed report before expanding.
Clinical standardization
Structure only helps when it preserves medical judgment
Lung-RADS 2 in screening reports. Lung-RADS 2 should explain why a finding is benign or probably benign while keeping recommendation and comparison traceable. Evaluation should cover structure, relevant negatives, measurements, comparison, and impression, not just AI.
Structure
Technique, findings, comparison, and impression must remain readable in both normal and abnormal exams.
Clinical language
Text should preserve modality terminology and avoid generic impressions unsupported by findings.
Review
The radiologist should see what was organized, what was inferred, and what needs confirmation before signing.
Decision criteria
Physician control
The radiologist reviews, edits, and signs. AI should accelerate report structure, not make the clinical decision.
Real integration
The tool should fit PACS/RIS, worklists, and exam context without forcing an infrastructure replacement.
Governance
Templates, history, permissions, and critical findings need to remain auditable as the service scales.
Measurable throughput
The improvement should show up in report time, rework, standardization, and operational safety.
Useful questions
What to confirm before moving forward
Which part of the workflow will be measured: dictation, review, signing, delivery, or rework?
Who can change templates, vocabulary, permissions, and service standards?
Which data enters the system and what stays out of pilot scope?
How are changes, access, critical findings, and integration failures audited?
30-day validation
By modality, test normal, abnormal, and borderline cases; measure physician corrections, relevant-negative consistency, and findings-to-impression coherence.
FAQ
When is Lung-RADS 2 in screening reports a good fit?
Lung-RADS 2 should explain why a finding is benign or probably benign while keeping recommendation and comparison traceable. A useful pilot checks curated clinical material, review quality, template fit, and integration friction.
Does this replace the radiologist?
No. Laudos.AI structures and accelerates the report, but the physician reviews, edits, and signs.
Does it require replacing PACS/RIS?
No. The intended deployment is to connect with existing infrastructure and keep the reporting flow familiar.